Concepedia

Roser López‐Alemany

RL

Statistics

Publications

19

Citations

796

H-Index

15

Active since

1993

Affiliations

Institut d'Investigació Biomédica de Bellvitge(Current)

Institut Català d'Oncologia

Centro de Investigación Biomédica en Red de Cáncer

Instituto de Salud Carlos III

Hospital Sant Joan de Déu Barcelona

Roser López‐Alemany is an author at Institut d'Investigació Biomédica de Bellvitge specializing in life sciences, molecular biology, and oncology.

ORCID

Publications per year

1993–2023

19

Publications

19

Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α‐Enolase

Roser López‐Alemany, Colin Longstaff, S B Hawley et al. · American Journal of Hematology · 2003 · 118 citations · Full text

, , +9

Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo

Mònica Suelves, Roser López‐Alemany, Frederic Lluı́s et al. · Blood · 2002 · 108 citations

, , +10

uPA deficiency exacerbates muscular dystrophy in <i>MDX</i> mice

Mònica Suelves, Berta Vidal, Antonio L. Serrano et al. · The Journal of Cell Biology · 2007 · 69 citations · Full text

, , +14

Plasminogen activator inhibitor type‐1 inhibits insulin signaling by competing with αvβ3 integrin for vitronectin binding

Roser López‐Alemany, Juan Miguel Redondo, Yoshikuni Nagamine et al. · European Journal of Biochemistry · 2003 · 66 citations · Full text

, , +15

EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma

Sílvia García-Monclús, Roser López‐Alemany, Olga Almacellas‐Rabaiget et al. · International Journal of Cancer · 2018 · 61 citations · Full text

, , +17

1–5 of 19